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The Cu,Zn superoxide dismutase (SOD1) is an ubiquitary cytosolic dimeric carbohydrate
free molecule, belonging to a family of isoenzymes involved in the scavenger of
superoxide anions. This effect certainly represents the main and well known function
ascribed to this enzyme. Here we highlight new aspects of SOD1 physiology that
point out some inedited effects of this enzyme in addition to the canonic role of
oxygen radical enzymatic dismutation. In the last two decades our research group
produced many data obtained in in vitro studies performed in many cellular lines, mainly
neuroblastoma SK-N-BE cells, indicating that this enzyme is secreted either constitutively
or after depolarization induced by high extracellular K+ concentration. In addition, we
gave many experimental evidences showing that SOD1 is able to stimulate, through
muscarinic M1 receptor, pathways involving ERK1/2, and AKT activation. These effects
are accompanied with an intracellular calcium increase. In the last part of this review we
describe researches that link deficient extracellular secretion of mutant SOD1G93A to its
intracellular accumulation and toxicity in NSC-34 cells. Alternatively, SOD1G93A toxicity
has been attributed to a decrease of Km for H2O2 with consequent OH radical formation.
Interestingly, this last inedited effect of SOD1G93A could represent a gain of function that
could be involved in the pathogenesis of familial Amyotrophic Lateral Sclerosis (fALS).
Keywords: CuZn superoxide dismutase, oxidative stress, muscarinic M1 receptor, transductional mechanisms,
secretion
INTRODUCTION
Superoxide dismutases (SODs) belong to the family of isoenzymes involved in the scavenging of
O2 radicals. All mammalian cells possess three isoforms of superoxide dismutase enzymes; the
cytosolic copper-zinc dimeric form, known as SOD1, the mitochondrial tetrameric manganese
superoxide dismutase or SOD2 (Weisiger and Fridovich, 1973) and the extracellular tetrameric
Cu,Zn superoxide dismutase or SOD3 (Marklund, 1982). All these enzymes catalyze the same
reaction converting the oxygen radical in molecular oxygen and hydrogen peroxide H2O2 through
the alternate reduction and reoxidation of Cu2+ for SOD1 and SOD3 and Mn for SOD2; the H2O2
is then enzymatically converted by catalase and glutathione peroxidase in molecular oxygen and
H2O.
The discovery of 32 kDa homodimeric protein Cu,Zn superoxide dismutase, SOD1, is due to
McCord and Fridovich studies (McCord and Fridovich, 1969). The SODs and the recognition of
their distribution in various aerobic organisms have important implications: first, the production
of the superoxide radical is inevitable because it is closely related to the metabolism of molecular
oxygen in mitochondria and in cellular membranes (Damiano et al., 2013, 2015; Accetta et al.,
2016); moreover, high levels of this radical, hydrogen peroxide, and hydroxyl radical, reactive
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oxygen species (ROS) cause oxidative stress and high cell toxicity
because they react with many organic molecules. The term
“oxidative stress” is referred to an imbalance between high levels
of ROS and low cellular antioxidant defenses (Halliwell, 2014).
The SODs represent the first enzymatic defense system against
radical damage by oxygen: thus, this enzyme is essential for all
aerobic organisms, but not for anaerobes. In support of this
hypothesis, McCord believed that the existence of an aerobic
organism depends mainly on its ability to produce SODs since its
deficiency is responsible for oxygen sensitivity and allows survival
only in an anaerobic environment.
The SOD1 is ubiquitous in mammalian cells and is expressed
at relatively high levels also in blood vessels; in normal mouse
aorta the activity of SOD1 accounts for 50–80% of total
SOD activity; a similar pattern of expression was observed in
human arteries (Horiuchi et al., 2004; Santillo et al., 2015). In
physiological conditions, the superoxide dismutases, together
with the non-enzymatic ROS scavengers as vitamins E, A, and C
maintain a steady state between oxidant and antioxidant systems
(Russo et al., 2011). The dysregulation in redox homeostasis,
determined by an imbalance between ROS production and
scavenging capacity, determines considerable cellular damage
as membrane lipoperoxidation, nucleic acid and structural
alterations of proteins contributing to neurodegenerative and
cardiovascular diseases.
The purpose of this review is to highlight new SOD1 functions
in addition to its canonic role of oxygen radical enzymatic
dismutation.
In the last years, many data obtained in in vitro studies
performed in many cellular lines, mainly neuroblastoma SK-N-
BE cells, indicate that SOD1 is secreted and is able to activate,
through muscarinic M1 receptor, cellular pathways involving
ERK1/2 and AKT activation; these effects are associated with
intracellular calcium increase that is further accentuated when
these cells are stimulated with mutated SOD1G93A.
CELLULAR LOCALIZATION OF SOD1 AND
EVIDENCES FOR CONSTITUTIVE SOD1
SECRETION
SOD1 is highly present in the cytosol but is also partially localized
in the mitochondrial matrix (Fukai and Ushio-Fukai, 2011)
where, instead, SOD2 is particularly expressed. The intracellular
cytosolic SOD1 localization has been a matter of debate;
recent evidences, performed in transfectedmouse neuroblastoma
neuro2 cells, demonstrated that both wild type SOD1 (wt-SOD1)
and SOD1 mutants are distributed into luminal structures of
endoplasmic and Golgi apparatus (Urushitani et al., 2008).
The first experimental evidence that some cellular lines could
be able to secrete the Cu,Zn superoxide dismutase date back to
many years ago when we, for the first time, showed the secretion
of this protein by experiments performed in hepatocytes and
fibroblasts (Mondola et al., 1996), neuroblastoma SK-N-BE cells
(Mondola et al., 1998; Gomes et al., 2007; Polazzi et al., 2013)
and in thymus derived epithelial cells (Cimini et al., 2002).
Interestingly, in further studies we observed the noticeable
presence of SOD1 in human serum lipoproteins, mainly in low
density (LDL) and high density (HDL) lipoproteins, ascribing
to this protein a protective role against the lipoperoxidation
(Mondola et al., 2000). In addition, we demonstrated that
in human neuroblastoma SK-N-BE cells, that show a greater
sensitivity to glucose deprivation-induced cytotoxicity due to
enhanced sensitivity to ROS (Shutt et al., 2010), SOD1 export
takes place in normal conditions and is increased following
oxidative stress (Mondola et al., 1996, 1998).
Successively, we showed that SOD1 in human neuroblastoma
SK-N-BE cells is exported through a microvesicular secretory
pathway that is impaired by brefeldin-A (BFA), and by 2-
deoxyglucose, and sodium azide, which reduces ATP intracellular
pool (Mondola et al., 2003). Moreover, in further studies we
indicated that in SK-N-BE cells SOD1 was able to activate PLC-
PKC pathway increasing intracellular calcium concentration
(Mondola et al., 2004).
INDUCIBLE SOD1 SECRETION IN
EXCITABLE CELLS
Another important aspect was the discovery that besides the
constitutive SOD1 export, the secretion of this enzyme is also
induced. To this respect, we showed (Santillo et al., 2007) that
SOD1 is actively released from rat brain synaptosomes as well as
from rat pituitary GH3 cells that represent a good model to study
the inducible SOD1 release since they possess all the neuronal
protein machinery involved in synaptic vesicle exocytosis. In
these cellular models we demonstrated, by confocal images and
Western Blotting experiments, that the depolarization, induced
by high extracellular K+ concentration, induced SOD1 release
correlated with an increase of intracellular calcium influx; these
effects were abolished by removal of extracellular calcium as well
as by cell preincubation either with calcium chelator EGTA or
with Botulinum toxin A that cleaves the SNARE protein, SNAP-
25. In addition, in the attempt to evaluate the possible role
carried out by SOD1 export, we recently demonstrated, in SK-
N-BE neuroblastoma cell line, that this enzyme is able, through
the involvement of muscarinic M1 receptor, to activate ERK1/2
and AKT in a dose and time-dependent manner. This effect was
remarkably reduced by M1 receptor silencing as well as by using
M1 antagonist pirenzepine (Damiano et al., 2013).
PATHWAY OF SOD1 EXPORT
Themajority of themembers of growth factors, Fibroblast growth
factor 1 and 2 (FGF-1 and FGF-2), are exported by Endoplasmic
Reticulum-Golgi (ERG) dependent secretory transport. However,
FGF-1 and the 18 kDa isoform of FGF-2 have been shown to
be secreted by an alternative pathway being directly translocated
from the cytoplasm into the extracellular space. Analogously,
also interleukin 1β (IL-1β) has been reported to be secreted by
a vesicular non-classical export pathway.
Soluble proteins classically contain N-terminal signal peptides
that direct them to the translocation apparatus of the
Endoplasmic Reticulum (ER) (Walter et al., 1984). Following
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vesicular transport from the ERG to the cell surface, proteins are
then released extracellularly by fusion of Golgi-derived secretory
vesicles with the cellular membrane (Palade, 1975; Rothman and
Wieland, 1996; Schekman and Orci, 1996; Mellman and Warren,
2000). In addition, non-classical protein secretion is both energy
and temperature dependent and can be stimulated or inhibited
by various treatments (Cleves, 1997; Hughes, 1999). The list of
proteins that could be exported from cells in the absence of a
functional ERG system (unconventional secretory pathway), as
IL-1β and galectin-1 (also referred to as L-14), is continually
growing; for further data see the review of Nickel (2003). It is
known that SOD1 is mainly a cytosolic protein that does not
possess a signal peptide for translocation into inner membrane
of ER. For this reason SOD1 secretion should bypass the
canonical ERG secretory pathway. We previously demonstrated
that BFA as well as 2-deoxyglucose and sodium azide (NaN3),
impairs SOD1 export (Mondola et al., 2003). In our opinion, the
treatment with BFA probably dysregulates not only the classical
secretory ERG pathway but also the microvesicular membrane
traffic of unconventional protein secretion or alternative protein
export. However, the export pathway of SOD1 has not yet been
clarified since some authors (Urushitani et al., 2008) indicated
an involvement of the ERG pathway; conversely, further studies
performed by confocal microscopy and immunoblotting (Atkin
et al., 2014) showed that wt-SOD1 or SOD1A4V, another mutant
form of SOD1, were not detected in the ER in NSC-34 cells.
Furthermore, these authors showed that SOD1A4V inhibits
secretory protein transport from the ER to the Golgi apparatus.
IMPAIRED SOD1 SECRETION IN
AMYOTROPHIC LATERAL SCLEROSIS
Amyotrophic lateral sclerosis (ALS) is an adult onset,
neurodegenerative disease characterized by selective death
of the upper and lower motor neurons of the brain and spinal
cord. Symptoms include muscle atrophy, spasticity, paralysis
and eventual death from respiratory failure within 3–5 years
of diagnosis. While ALS mostly affects patients without family
histories of the disease, 5–10% of ALS is familial (fALS).
Clinical and pathological processes indicate that ER stress
represents a key pathway involved in cell death. In the transgenic
SOD1G93A ALS rat model unfolded protein response and ER
stress-induced apoptosis has been observed (Atkin et al., 2006);
an unfolded protein response, including induction of stress
sensor kinases, chaperones, and apoptotic mediators, has been
shown also in spinal cord motor neurons of human patients with
the sporadic form of ALS (sALS) that is not restricted to SOD1
mutations (Atkin et al., 2008).
However, the link between the pathogenic mechanisms of
fALS and sALS remains unclear, since in the latter, misfolded wt-
SOD1 protein activates the same neurotoxic mechanism that is
invoked by SOD1 mutants in fALS (Bosco et al., 2010; Forsberg
et al., 2010).
SOD1 and other proteins are misfolded in fALS and in sALS,
but it is not clear how this triggers ER stress, fragmentation
of the Golgi apparatus, disruption of axonal transport and
apoptosis. Nearly 20% of fALS is caused by SOD1 gene mutations
(Neumann et al., 2006). Indeed, the majority of SOD1 mutants
maintain their enzymatic activity suggesting the occurrence of
gain of toxic activity function rather than a simple loss of function
(Strong et al., 2005; Dion et al., 2009).
Turner et al. (2005) demonstrated an impaired constitutive
extracellular secretion of mutant SOD1 in NSC-34 cells that
induces frequent cytoplasmic inclusions and protein insolubility.
These data link the deficient secretion of mutant SOD1 with
intracellular protein aggregates and toxicity in NSC-34 cells. In
addition, these authors showed that in a transgenic rat model
of ALS the chronic intraspinal infusion of exogenous human
wt-SOD1 significantly delayed disease progression suggesting a
novel extracellular role for SOD1 in ALS; therefore extracellular
delivery of human wt-SOD1 could improve clinical disease
in transgenic ALS rats supporting a novel extracellular role
for mutant and wt-SOD1 in ALS pathogenesis and therapy,
respectively.
Moreover, recent studies demonstrate that SOD1 mutants
can also be exported; in fact, although SOD1 inclusions are
exclusively intracellular, there is evidence that these inclusions
can escape from the cytoplasm and come into contact with
nearby neuronal cells (Münch et al., 2011). In addition, in
transgenic mice, carrying SOD1 mutations, toxic effects to motor
neurons by microglia activation were observed (Urushitani et al.,
2006; Zhao et al., 2010).
The microglia cells can carry out an important role in
ALS progression (Pramatarova et al., 2001) since microglia
activation can be observed before neuron loss in transgenic mice
expressing human SOD1 mutants (Alexianu et al., 2001). Data
from experiments conducted in wt/mutant SOD1 chimeric mice
demonstrated that mice with wt-SOD1 glial cells live longer,
suggesting that glial cells containing SOD1 mutants contribute
to disease (Clement et al., 2003). The pathogenic role of mutated
SOD1 has not yet been completely clarified. The involvement of
deranged inflammatory processes in ALS pathogenesis has been
largely suggested.
It is believed that ER stress is triggered when proteins
accumulate within the ER lumen. ER stress can also be caused
by other mechanisms such as inhibition of ERG transport, which
results in accumulation of secretory proteins within the ER
(Høyer-Hansen and Jäättelä, 2007; Preston et al., 2009; Araki
et al., 2012). Our first demonstrations of SOD1 secretion in many
cellular lines stimulated many researches in order to study the
secretory pathway of this protein in a ALS.
As it is known, mutations of SOD1 in transgenic rats or
mice induced motor neuron disease (Gurney, 1994; Howland
et al., 2002) and are associated with about 20% of fALS. In
addition, SOD1G93A causes protein aggregation inducing cellular
damage (Bendotti and Carrì, 2004; Bruijn et al., 2004). As has
been previously evaluated, about one third of all proteins transit
trough the ER and Golgi compartments (Ghaemmaghami et al.,
2003) and the coat protein II complex, (COPII) constituted by
five subunits: Sar1, Sec23, Sec24, Sec13, and Sec31 (Lee and
Goldberg, 2010) is considered to carry out a central role in
this process. Restoration of ERG transport by over-expression of
coatomer coat protein II subunit Sar1 protected against inclusion
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formation and apoptosis, linking dysfunction in ERG transport
to cellular pathology. These results suggest that several cellular
events in ALS are linked into a single mechanism occurring early
in mutated SOD1 expressing cells. Therefore, even if mutated
SOD1 inhibits ERG transport, the mechanism by which SOD1
mutants are toxic is still unknown. The microglial activation, due
to mutated SOD escaped from the cell could have, a relevant
role. In a recent review, it is suggested that post-translational
modifications of SOD1 could cause wild type to adopt a “toxic
conformation” that is similar to fALS-linked SOD1 variants.
These observations, together with the detection of misfolded wt-
SOD1 within human post mortem sALS samples, have been used
to support the controversial hypothesis that misfolded forms of
wt-SOD1 contribute to sALS pathogenesis (Rotunno and Bosco,
2013).
SOD1 AS NEUROMODULATOR
Many studies pointed out that muscarinic receptors are widely
expressed in the central nervous system controlling several
neuronal functions; in addition, it has been shown that the
activation of muscarinic M1 acetylcholine receptor coupled to
Gq11 increases extracellular signaling-regulated protein kinase
(ERK 1/2) modulating synaptic transmission (Hamilton et al.,
2001; Anagnostaras et al., 2003; Scheiderer et al., 2006; McCoy
and McMahon, 2007). In further studies, we demonstrated
(Mondola et al., 2004) that the incubation of SOD1 with SK-
N-BE cells activated a PLC–PKC-dependent pathway inducing
a relevant intracellular [Ca2+]i increase. The specificity of
SOD1 surface binding to SK-N-BE membrane was strengthened
by the fact that neither biotinylated human thyroglobulin
nor human thyroperoxidase bound to the neuroblastoma cell
membranes. Moreover, our data showed that the effect of
SOD1 was independent of dismutase activity, since the SOD
mimetic substance, MnTMPyP, failed to produce the same effects.
On the other hand, ApoSOD (free metal type 1 superoxide
dismutase) was able to reproduce the same SOD1 effects
mentioned above suggesting a new function of superoxide
dismutase independently from its dismutase activity. Notably,
SOD1 induced an increase in [Ca2+]i by intracellular and
extracellular dependent mechanisms. Indeed, since the increase
in [Ca2+]i was only partially reduced in the free calciummedium,
we hypothesized that intracellular calcium stores were involved
in this change. In addition, the ability of 0.1 µM ω-conotoxin
and 1 µM nimodipine to inhibit only in part this effect indicated
that N and L types of VGCCs could elicit SOD1-dependent
intracellular Ca2+ increase; therefore this effect should be better
investigated. Moreover, our data indicate that U73122, the PLC
inhibitor, completely reduced SOD1-induced [Ca2+]i increase
(Mondola et al., 2004). These and previous data pointed out
that SOD1, through an increase of calcium-dependent signaling,
could affect different biological functions besides acting as
scavenger of superoxide radical. The paracrine role carried out
by SOD1 could also explain the other function ascribed to this
protein (Mondola et al., 2002; De Felice et al., 2004; Viggiano
et al., 2012; Terrazzano et al., 2014).
SOD1 MUSCARINIC M1 RECEPTOR
INTERACTION
Muscarinic M1 receptor represents the predominant subtype of
muscarinic acetylcholine receptors in the central nervous system
(CNS); this receptor, localized at post-synaptic level in the cortex,
hippocampus, striatum, and thalamus (Ellis, 2002), activates the
extracellular signal-regulated kinase pathway (Berkeley et al.,
2001). Recently, it has been demonstrated that the stimulation
of M1 receptor attenuates the disease progression in subjects
affected by Alzheimer disease (AD) (Caccamo et al., 2006);
moreover, it has been hypothesized that selective activation of
muscarinic M1 receptor could lead to improvement of cognitive
aspects in schizophrenic patients.
Our previous data showed the secretion of SOD1 in many
cellular lines (Mondola et al., 1996, 1998, 2002); in addition,
further cytofluorimetric studies demonstrated a specific SOD1
interaction with the plasmamembrane of neuroblastoma SK-
N-BE cells that results in an activation of phospholipase C
(PLC) transductional mechanisms associated to a slight increase
of intracellular calcium concentration (Mondola et al., 2004;
Damiano et al., 2013).
Using rat pituitary GH3 cells that express the neural protein
machinery involved in vesicle neurosecretion, we demonstrated
the presence of SOD1 in large core dense vesicles; moreover,
we showed that SOD1 is secreted in response to high (55 mM)
extracellular K+ concentration (Santillo et al., 2007).
Recently, we showed that SOD1 activates muscarinic M1
receptor inducing a phosphorylation of ERK1/2 and AKT in
a dose and time dependent manner in neuroblastoma SK-N-
BE cells; in fact, in presence of M1 antagonist pirenzepine,
ERK1/2 and AKT phosphorylation, induced by SOD1, was
strongly prevented. A further involvement of M1 muscarinic
receptor was confirmed by knocking-down experiments using
two sequences of human M1 receptor small interfering RNAs
and by aM1 stimulator (oxotremorine) that respectively decrease
and increase activation of ERK1/2 and AKT, suggesting a
neuromodulatory effect of SOD1 (Damiano et al., 2013).
CONCLUSIONS
This review is an update and expansion of many of our researches
dating back to many years ago when we, for the first time, gave
experimental evidences of SOD1 secretion in different cellular
lines. Based on the evidence of secretory pathway dysfunction
in ALS, Turner et al. (2005) confirmed our previous researches
related to SOD1 secretion also in mouse motoneuron like NSC-
34 cells; in addition, these authors linked deficient extracellular
accumulation of SOD1 mutants to intracellular aggregates and
toxicity in NSC-34 cells demonstrating that extracellular delivery
of human wt-SOD1 improved clinical disease in transgenic ALS
rats.
Previous research (Yim et al., 1996) shows that, in transgenic
mice, both the wt-SOD1 and the SOD1G93A exhibit identical
catalytic activity for the dismutation of superoxide anion, while
the SOD1G93A shows a decrease of Km for H2O2 with a
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FIGURE 1 | Schematic representation of new SOD1 effects obtained in in vitro and in vivo experiments.
FIGURE 2 | Schematic representation of vesicular SOD1 secretion and transduction pathways activated in excitable cells.
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consequent OH◦ radical formation. Therefore, ALS symptoms
observed in SOD1G93A transgenic mice could be caused by a
gain-of-function of the mutated form of the enzyme.
This effect can be due to SOD1G93A fALS mutant that exhibits
a higher activity for catalyzing the generation of free radicals at
subsaturating level of H2O2. In addition, this enhancement of the
free radical-generating function will also promote inactivation
of the mutant enzyme which may lead to the release of copper
ions from the inactivated protein that may be in part, responsible
for the development of ALS symptoms. However, the nature of
this cytotoxic gain-of-function of the fALS mutant is yet to be
identified.
Another more recent research pointed out that wt-SOD1 was
present in the cytoplasm and in less extent in the nuclei of motor
neurons, whereas SOD1G93A mutant was strongly localized in
the nucleus (Gertz et al., 2012). wt-SOD1 has also been detected
in peroxisomes of rat hepatocytes and fibroblasts (Dhaunsi
et al., 1992; Wanders and Denis, 1992). The proteasome activity
analysis, responsible for misfolded protein clearance, performed
in the two subcellular compartments, demonstrated proteasome
impairment only in the cytoplasm. The effect of SOD1G93A
exclusion from nuclei, analyzed after oxidative stress, showed a
higher DNA damage compared with those expressing wt-SOD1,
possibly because of a loss of nuclear protection. The toxicity of
SOD1 mutants could be attributed to an initial misfolding (gain
of function) reducing nuclear protection from the active enzyme
(loss of function in the nuclei), a process that may be involved in
ALS pathogenesis (Sau et al., 2007).
The results of our research performed in the last decade
indicate that this enzyme cannot be considered exclusively as
an antioxidant molecule able to carry out the dismutation of
superoxide anion. In Figure 1, in addition to the activation of the
transduction pathway involving M1 muscarinic receptor,
other inedited SOD1 effects on cholesterol metabolism
and synaptic modulation in rat dentate gyrus are shown
(Mondola et al., 2002; De Felice et al., 2004; Viggiano et al.,
2012). The inducible SOD1 vesicular mediated secretion
and activation of ERK1/2 and AKT through SOD1-M1
muscarinic receptor pathway, associated to increased
intracellular calcium concentration, indicates a paracrine
role of this molecule as shown in Figure 2 (Damiano et al.,
2013). The mechanism by which mutated SOD1G93A causes
ER stress and Golgi apparatus fragmentation, in addition
to accumulation of misfolded or unfolded proteins at the
ER lumen, has been widely studied but has not yet been
completely clarified (Turner et al., 2005; Turner and Atkin, 2006;
Nassif et al., 2010). Moreover, in further studies, it could be
worthwhile to evaluate if the mutated SOD1G93A, analogously
to wt-SOD1, induces the same effect on the activation of
muscarinic M1 receptor involved in ERK/AKT/Ca++i pathway
modulation.
AUTHOR CONTRIBUTIONS
PM Conceived and wrote the review article. SD, AS, and MS
contributed to write the paper.
REFERENCES
Accetta, R., Damiano, S., Morano, A., Mondola, P., Paternò, R., Avvedimento,
E. V., et al. (2016). Reactive oxygen species derived from NOX3 and NOX5
drive differentiation of human oligodendrocytes. Front. Cell. Neurosci. 10:146.
doi: 10.3389/fncel.2016.00146
Alexianu, M. E., Kozovska, M., and Appel, S. H. (2001). Immune reactivity in a
mouse model of familial ALS correlates with disease progression.Neurology 57,
1282–1289. doi: 10.1212/WNL.57.7.1282
Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama,
N. P., Nathanson, N. M., et al. (2003). Selective cognitive dysfunction in
acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 6, 51–58.
doi: 10.1038/nn992
Araki, T., Nagano, S., Tateno, M., Kaido, M., Ogata, K., Arima, K., et al. (2012).
Misfolded SOD1 forms high-density molecular complexes with synaptic
molecules in mutant SOD1-linked familial amyotrophic lateral sclerosis cases.
J. Neurol. Sci. 314, 92–96. doi: 10.1016/j.jns.2011.10.017
Atkin, J. D., Farg, M. A., Soo, K. Y., Walker, A. K., Halloran, M., Turner, B. J.,
et al. (2014). Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral
sclerosis. J. Neurochem. 129, 190–204. doi: 10.1111/jnc.12493
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., et al.
(2006). Induction of the unfolded protein response in familial amyotrophic
lateral sclerosis and association of protein-disulfide isomerase with superoxide
dismutase 1. J. Biol. Chem. 281, 30152–31065. doi: 10.1074/jbc.M603
393200
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., and Horne, M.
K. (2008). Endoplasmic reticulum stress and induction of the unfolded protein
response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 30,
400–407. doi: 10.1016/j.nbd.2008.02.009
Bendotti, C., and Carrì, M. T. (2004). Lessons frommodels of SOD1-linked familial
ALS. Trends Mol. Med. 10, 393–400. doi: 10.1016/j.molmed.2004.06.009
Berkeley, J. L., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., and Levey,
A. I. (2001). M1muscarinic acetylcholine receptors activate extracellular signal-
regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices.Mol.
Cell. Neurosci. 18, 512–524. doi: 10.1006/mcne.2001.1042
Bosco, D. A., Morfini, G., Karabacak, N. M., Song, Y., Gros-Louis, F., Pasinelli,
P., et al. (2010). Wild-type and mutant SOD1 share an aberrant conformation
and a common pathogenic pathway in ALS. Nat. Neurosci. 13, 1396–1403.
doi: 10.1038/nn.2660
Bruijn, L. I., Miller, T. M., and Cleveland, D. W. (2004). Unraveling the
mechanisms involved in motor neuron degeneration in ALS. Annu. Rev.
Neurosci. 27, 723–749. doi: 10.1146/annurev.neuro.27.070203.144244
Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria,
H., Fisher, A., et al. (2006). M1 receptors play a central role in
modulating AD-like pathology in transgenic mice. Neuron. Mar. 49, 671–682.
doi: 10.1016/j.neuron.2006.01.020
Cimini, V., Ruggiero, G., Buonomo, T., Seru, R., Sciorio, S., Zanzi, C., et al.
(2002). CuZn-superoxide dismutase in human thymus: immunocytochemical
localisation and secretion in thymus-derived epithelial and fibroblast cell lines.
Histochem. Cell Biol. 118, 163–169. doi: 10.1007/s00418-002-0429-8
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée,
S., Rule, M., et al. (2003). Wild-type nonneuronal cells extend survival
of SOD1 mutant motor neurons in ALS mice. Science 302, 113–117.
doi: 10.1126/science.1086071
Cleves, A. E. (1997). Protein transports: the nonclassical ins and outs. Curr. Biol. 7,
318–320.
Damiano, S., Morano, A., Ucci, V., Accetta, R., Mondola, P., Paternò, R., et al.
(2015). Dual oxidase 2 generated reactive oxygen species selectively mediate the
induction of mucins by epidermal growth factor in enterocytes. Int. J. Biochem.
Cell Biol. 60, 8–18. doi: 10.1016/j.biocel.2014.12.014
Damiano, S., Petrozziello, T., Ucci, V., Amente, S., Santillo, M., and Mondola,
P. (2013). Cu-Zn superoxide dismutase activates muscarinic acetylcholine
Frontiers in Physiology | www.frontiersin.org 6 November 2016 | Volume 7 | Article 594
Mondola et al. New Functions of SOD1
M1 receptor pathway in neuroblastoma cells. Mol. Cell. Neurosci. 52, 31–37.
doi: 10.1016/j.mcn.2012.11.001
De Felice, B., Santillo, M., Serù, R., Damiano, S., Matrone, G., Wilson, R. R.,
et al. (2004). Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase gene
expression by CuZn superoxide dismutase in human fibroblasts and HepG2
cells. Gene Expr. 12, 29–38. doi: 10.3727/000000004783992198
Dhaunsi, G. S., Gulati, S., Singh, A. K., Orak, J. K., Asayama, K., and
Singh, I. (1992). Demonstration of Cu-Zn superoxide dismutase in rat liver
peroxisomes. Biochemical and immunochemical evidence. J. Biol. Chem. 267,
6870-6873.
Dion, P. A., Daoud, H., and Rouleau, G. A. (2009). Genetics of motor neuron
disorders: new insights into pathogenic mechanisms. Nat. Rev. Genet. 10,
769–782. doi: 10.1038/nrg2680
Ellis J. (2002). “Muscarinic receptors,” in Understanding G Protein-Coupled
Receptors and Their Role in the CNS, eds M. N. Pangalos and C. H. Davies
(Oxford: Oxford University Press), 349–371.
Forsberg, K., Jonsson, P. A., Andersen, P. M., Bergemalm, D., Graffmo,
K. S., Hultdin, M., et al. (2010). Novel antibodies reveal inclusions
containing non-native SOD1 in sporadic ALS patients. PLoS ONE 5:e11552.
doi: 10.1371/journal.pone.0011552
Fukai, T., and Ushio-Fukai, M. (2011). Superoxide dismutases: role in redox
signaling, vascular function, and diseases. Antioxid. Redox Signal. 15,
1583–1606. doi: 10.1089/ars.2011.3999
Gertz, B., Wong, M., and Martin, L. J. (2012). Nuclear localization of human
SOD1 and mutant SOD1-specific disruption of survival motor neuron protein
complex in transgenic amyotrophic lateral sclerosis mice. J. Neuropathol. Exp.
Neurol. 71, 162–177. doi: 10.1097/NEN.0b013e318244b635
Ghaemmaghami, S., Huh, W. K., Bower, K., Howson, R. W., Belle, A., Dephoure,
N., et al. (2003). Global analysis of protein expression in yeast. Nature 425,
737–741. doi: 10.1038/nature02046
Gomes, C., Keller, S., Altevogt, P., and Costa, J. (2007). Evidence for secretion of
Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic
lateral sclerosis. Neurosci. Lett. 428, 43–46. doi: 10.1016/j.neulet.2007.09.024
Gurney, M. E. (1994). Transgenic-mouse model of amyotrophic lateral sclerosis.
N. Engl. J. Med. 331, 1721–1722. doi: 10.1056/NEJM199412223312516
Halliwell, B. (2014). Cell culture, oxidative stress, and antioxidants: avoiding
pitfalls. Biomed. J. 37, 99–105. doi: 10.4103/2319-4170.128725
Hamilton, S. E., Hardouin, S. N., Anagnostaras, S. G., Murphy, G. G.,
Richmond, K. N., Silva, A. J., et al. (2001). Alteration of cardiovascular
and neuronal function in M1 knockout mice. Life Sci. 68, 2489–2493.
doi: 10.1016/S0024-3205(01)01043-8
Horiuchi, M., Tsutsui, M., Tasaki, H., Morishita, T., Suda, O., Nakata, S., et al.
(2004). Upregulation of vascular extracellular superoxide dismutase in patients
with acute coronary syndromes. Arterioscler. Thromb. Vasc. Biol. 24, 106–101.
doi: 10.1161/01.ATV.0000104240.56460.AB
Howland, D. S., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B., et al. (2002).
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of
SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad.
Sci. U.S.A. 99, 1604–1609. doi: 10.1073/pnas.032539299
Høyer-Hansen, M., and Jäättelä, M. (2007). Connecting endoplasmic reticulum
stress to autophagy by unfolded protein response and calcium. Cell Death
Differ. 14, 1576–1582. doi: 10.1038/sj.cdd.4402200
Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydrate-
binding proteins. Biochim. Biophys. Acta 1473, 172–185.
Lee, C., and Goldberg, J. (2010). Structure of coatomer cage proteins and the
relationship among COPI, COPII, and clathrin vesicle coats. Cell 142, 123–132.
doi: 10.1016/j.cell.2010.05.030
Marklund, S. L. (1982). Human copper-containing superoxide dismutase of high
molecular weight. Proc. Natl. Acad. Sci. U.S.A. 79, 7634–7638.
McCord, J. M., and Fridovich, I. (1969). Superoxide dismutase. An enzymic
function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049–6055.
McCoy, P. A., and McMahon, L. L. (2007). Muscarinic receptor dependent
long-term depression in rat visual cortex is PKC independent but requires
ERK1/2 activation and protein synthesis. J. Neurophysiol. 98, 1862–1870.
doi: 10.1152/jn.00510.2007
Mellman, I., and Warren, G. (2000). The road taken: past and future foundations
of membrane traffic. Cell 100, 99–112. doi: 10.1016/S0092-8674(00)81687-6
Mondola, P., Annella, T., Santillo, M., and Santangelo, F. (1996).
Evidence for secretion of cytosolic CuZn superoxide dismutase by
Hep G2 cells and human fibroblasts. Int. J. Biochem. Cell. Biol. 28,
677–681.
Mondola, P., Annella, T., Serù, R., Santangelo, F., Iossa, S., Gioielli, A., et al. (1998).
Secretion and increase of intracellular CuZn superoxide dismutase content in
human neuroblastoma SK-N-BE cells subjected to oxidative stress. Brain Res.
Bull. 45, 517–520.
Mondola, P., Bifulco, M., Serù, R., Annella, T., Ciriolo, M. R., and Santillo, M.
(2000). Presence of CuZn superoxide dismutase in human serum lipoproteins.
FEBS Lett. 467, 57–60. doi: 10.1016/S0014-5793(00)01123-6
Mondola, P., Ruggiero, G., Serù, R., Damiano, S., Grimaldi, S., Garbi, C., et al.
(2003). The Cu,Zn superoxide dismutase in neuroblastoma SK-N-BE cells is
exported by a microvesicles dependent pathway. Brain Res. Mol. Brain Res. 110,
45–51. doi: 10.1016/S0169-328X(02)00583-1
Mondola, P., Santillo, M., Serù, R., Damiano, S., Alvino, C., Ruggiero, G., et al.
(2004). Cu,Zn superoxide dismutase increases intracellular calcium levels via
a phospholipase C-protein kinase C pathway in SK-N-BE neuroblastoma cells.
Biochem. Biophys. Res. Commun. 324, 887–892. doi: 10.1016/j.bbrc.2004.09.131
Mondola, P., Serù, R., Santillo, M., Damiano, S., Bifulco, M., Laezza, C., et al.
(2002). Effect of Cu,Zn superoxide dismutase on cholesterol metabolism in
human hepatocarcinoma (HepG2) cells. Biochem. Biophys. Res. Commun. 295,
603–609. doi: 10.1016/S0006-291X(02)00720-9
Münch, C., O’Brien, J., and Bertolotti, A. (2011). Prion-like propagation of mutant
superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci.
U.S.A. 108, 3548–3553. doi: 10.1073/pnas.1017275108
Nassif, M., Matus, S., Castillo, K., and Hetz, C. (2010). Amyotrophic lateral
sclerosis pathogenesis: a journey through the secretory pathway. Antioxid.
Redox Signal. 13, 1955–1989. doi: 10.1089/ars.2009.2991
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micseny, M.
C., Chou, T. T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal
lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133.
doi: 10.1126/science.1134108
Nickel, W. (2003). The mystery of nonclassical protein secretion. A current view
on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119.
doi: 10.1046/j.1432-1033.2003.03577.x
Palade, G. (1975). Intracellular aspects of the process of protein synthesis. Science
189, 347–358.
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., and Monti,
B. (2013). Copper-zinc superoxide dismutase (SOD1) is released by microglial
cells and confers neuroprotection against 6-OHDA neurotoxicity. Neurosignals
21, 112–128. doi: 10.1159/000337115
Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., and Rouleau, G. A. (2001).
Neuron-specific expression of mutant superoxide dismutase 1 in transgenic
mice does not lead to motor impairment. J. Neurosci. 21, 3369-3374.
Preston, A. M., Gurisik, E., Bartley, C., Laybutt, D. R., and Biden, T. J. (2009).
Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes
to ER stress in lipotoxic mouse beta cells by promoting protein overload.
Diabetologia 52, 2369–2373. doi: 10.1007/s00125-009-1506-5
Rothman, J. E., and Wieland, F. T. (1996). Protein sorting by transport vesicles.
Science 272, 227–234.
Rotunno, M. S., and Bosco, D. A. (2013). An emerging role for misfolded
wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell. Neurosci. 7:253.
doi: 10.3389/fncel.2013.00253
Russo, M., Cocco, S., Secondo, A., Adornetto, A., Bassi, A., Nunziata, A., et al.
(2011). Cigarette smoke condensate causes a decrease of the gene expression
of Cu-Zn superoxide dismutase, Mn superoxide dismutase, glutathione
peroxidase, catalase, and free radical-induced cell injury in SH-SY5Y human
neuroblastoma cells. Neurotox. Res. 19, 49–54. doi: 10.1007/s12640-009-
9138-6
Santillo, M., Colantuoni, A., Mondola, P., Guida, B., and Damiano, S. (2015).
NOX signaling in molecular cardiovascular mechanisms involved in the
blood pressure homeostasis. Front. Physiol. 6:194. doi: 10.3389/fphys.2015.
00194
Santillo, M., Secondo, A., Serù, R., Damiano, S., Garbi, C., Taverna, E.,
et al. (2007). Evidence of calcium- and SNARE-dependent release
of CuZn superoxide dismutase from rat pituitary GH3 cells and
Frontiers in Physiology | www.frontiersin.org 7 November 2016 | Volume 7 | Article 594
Mondola et al. New Functions of SOD1
synaptosomes in response to depolarization. J. Neurochem. 102, 679–685.
doi: 10.1111/j.1471-4159.2007.04538.x
Sau, D., De Biasi, S., Vitellaro-Zuccarello, L., Riso, P., Guarnieri, S., Porrini, M.,
et al. (2007). Mutation of SOD1 in ALS: a gain of a loss of function. Hum. Mol.
Genet. 16, 1604–1618. doi: 10.1093/hmg/ddm110
Scheiderer, C. L., McCutchen, E., Thacker, E. E., Kolasa, K., Ward, M.
K., Parsons, D., et al. (2006). Sympathetic sprouting drives hippocampal
cholinergic reinnervation that prevents loss of a muscarinic receptor-
dependent long-term depression at CA3-CA1 synapses. J. Neurosci. 26,
3745–3756. doi: 10.1523/JNEUROSCI.5507-05.2006
Schekman, R., and Orci, L. (1996). Coat proteins and vesicle budding. Science 271,
1526–1533.
Shutt, D. C., O’Dorisio, M. S., Aykin-Burns, N., and Spitz, D. R. (2010). 2-deoxy-D-
glucose induces oxidative stress and cell killing in human neuroblastoma cells.
Cancer Biol Ther. 9, 853–861.
Strong, M. J., Kesavapany, S., and Pant, H. C. (2005). The pathobiology of
amyotrophic lateral sclerosis: a proteinopathy? J. Neuropathol. Exp. Neurol. 64,
649–664.
Terrazzano, G., Rubino, V., Damiano, S., Sasso, A., Petrozziello, T., Ucci, V.,
et al. (2014). T cell activation induces CuZn superoxide dismutase (SOD)-1
intracellular re-localization, production and secretion. Biochim. Biophys. Acta
1843, 265–274. doi: 10.1016/j.bbamcr.2013.10.020
Turner, B. J., and Atkin, J. D. (2006). ER stress and UPR in familial amyotrophic
lateral sclerosis. Curr. Mol. Med. 6, 79–86. doi: 10.2174/156652406775574550
Turner, B. J., Atkin, J. D., Farg, M. A., Zang, D. W., Rembach, A.,
Lopes, E. C., et al. (2005). Impaired extracellular secretion of mutant
superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic
lateral sclerosis. J. Neurosci. 25, 108–117. doi: 10.1523/JNEUROSCI.4253-0
4.2005
Urushitani, M., Ezzi, S. A., Matsuo, A., Tooyama, I., and Julien, J. P. (2008).
The endoplasmic reticulum-Golgi pathway is a target for translocation and
aggregation of mutant superoxide dismutase linked to ALS. FASEB J. 22,
2476–2487. doi: 10.1096/fj.07-092783
Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., and Julien, J. P.
(2006). Chromogranin-mediated secretion of mutant superoxide dismutase
proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108–118.
doi: 10.1038/nn1603
Viggiano, A., Serù, R., Damiano, S., De Luca, B., Santillo, M., and Mondola, P.
(2012). Inhibition of long-term potentiation by CuZn superoxide dismutase
injection in rat dentate gyrus: involvement of muscarinic M1 receptor. J. Cell.
Physiol. 227, 3111–3115. doi: 10.1002/jcp.23062
Walter, P., Gilmore, R., and Blobel, G. (1984). Protein translocation across the
endoplasmic reticulum. Cell. 38, 5–8.
Wanders, R. J., and Denis, S. (1992). Identification of superoxide dismutase in rat
liver peroxisomes. Biochim. Biophys. Acta 1115, 259–262.
Weisiger, R. A., and Fridovich, I. (1973). Mitochondrial superoxide simutase. Site
of synthesis and intramitochondrial localization. J. Biol. Chem. 248, 4793–4796.
Yim, M. B., Kang, J. H., Yim, H. S., Kwak, H. S., Chock, P. B., and Stadtman, E.
R. (1996). A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,
Zn-superoxide dismutase mutant: an enhancement of free radical formation
due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. U.S.A. 93,
5709–5714.
Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J. P., et al.
(2010). Extracellular mutant SOD1 induces microglial-mediated motoneuron
injury. Glia 58, 231–243. doi: 10.1002/glia.20919
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Mondola, Damiano, Sasso and Santillo. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 8 November 2016 | Volume 7 | Article 594
